comparemela.com

Latest Breaking News On - Jon stonehouse - Page 1 : comparemela.com

BioCryst Pharmaceuticals, Inc.: BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update

BioCryst Pharmaceuticals, Inc.: BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United-states
America
Helen-thackray
John-bluth
Charlie-gayer
Jon-stonehouse
Biocryst-pharmaceuticals-inc
International-society-for-pharmacoeconomics
Linkedin
Biocryst-pharmaceuticals
Outcomes-research
Exchange-commission

Why Is BioCryst Stock Trading Higher On Monday? - BioCryst Pharma (NASDAQ:BCRX)

BioCryst's impressive first-quarter earnings report surpasses estimates. Sales surged to $92.8 million, primarily driven by Orladeyo revenue growth. With strong patient demand and strategic initiatives, BioCryst projects robust revenue

United-states
Biocryst-pharma
Jon-stonehouse
Biocryst-pharmaceuticals-inc
Biocryst-pharmaceuticals
Cryst-pharma

BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability

BioCryst Announces Preliminary Full Year 2023 ORLADEYO® (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alabama
United-states
San-francisco
California
John-bluth
Jon-stonehouse
Charlie-gayer
Biocryst-pharmaceuticals
Discovery-center
Nasdaq
Biocryst-pharmaceuticals-inc
Linkedin

vimarsana © 2020. All Rights Reserved.